Axon Enterprise (NASDAQ:AXON) Lifted to Overweight at JPMorgan Chase & Co.
JPMorgan Chase & Co. upgraded shares of Axon Enterprise (NASDAQ:AXON – Get Rating) from a neutral rating to an overweight rating in a report published on Thursday, The Fly reports. The brokerage currently has $236.00 price objective on the biotechnology company’s stock. Several other research firms have also commented on AXON. Raymond James lowered Axon […]